ArticleThe journal of allergy and clinical immunology. Global2023

Elaborate biologic approval process delays care of patients with moderate-to-severe asthma.

Esha Sehanobish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.